DekaBank Deutsche Girozentrale
GEVA

DekaBank Deutsche Girozentrale’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,310
Closed -$1.69M – 1210
2015
Q1 		$1.69M Sell
17,310
-490
-3% -$51.9K 0.02% 478
2014
Q4 		$1.61M Sell
17,800
-1,600
-8% -$126K 0.02% 495
2014
Q3 		$1.33M Buy
19,400
+450
+2% +$32.2K 0.02% 480
2014
Q2 		$1.99M Buy
18,950
+300
+2% +$25.5K 0.03% 418
2014
Q1 		$1.55M Buy
18,650
+1,150
+7% +$106K 0.02% 413
2013
Q4 		$1.16M Buy
17,500
+2,300
+15% +$137K 0.02% 408
2013
Q3 		$964K Buy
15,200
+1,200
+9% +$59.1K 0.02% 440
2013
Q2 		$601K Buy
+14,000
New +$638K 0.01% 440

DekaBank Deutsche Girozentrale's GEVA Position: Q2 2015 in Review

DekaBank Deutsche Girozentrale sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 17,310 shares — an estimated $1.69M sold.

DekaBank Deutsche Girozentrale first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.99M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • DekaBank Deutsche Girozentrale reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 17,310 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.69M.
  • DekaBank Deutsche Girozentrale first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • DekaBank Deutsche Girozentrale's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.99M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2015, filed 13 Aug 2015.